CoChat

Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model

Cao, Bao, Christophersen, Lars, Thomsen, Kim, Sønderholm, Majken, Bjarnsholt, Thomas, Jensen, Peter Østrup, Høiby, Niels, Moser, Claus · 2015 · Journal of Antimicrobial Chemotherapy
Cited by 68

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Objectives: Treating biofilm infections successfully is a challenge. We hypothesized that biofilms may be considered as independent compartments with particular pharmacokinetics. We therefore studied the pharmacokinetics and pharmacodynamics of tobramycin in a seaweed alginate-embedded biofilm model. Methods: Seaweed alginate beads containing Pseudomonas aeruginosa were cultured in LB medium, sampled at day 1, 3, 5 or 7 and examined for the effect of treatment with tobramycin for 30 min. Treated beads were homogenized and the number of cfu was determined. The antibiotic concentration in the solution of homogenized beads was measured. Finally, beads were examined for live cells by Syto9 staining and for dead cells by propidium iodide staining using a confocal laser scanning microscope. Results: The antibiotic level in each bead was relatively stable (range 30–42 mg/L; MIC = 1.5 mg/L). There were fewer cfu in the tobramycin-treated beads than the non-treated beads (P < 0.016) and bacterial killing was reduced as the culture period increased from 1 to 7 days. Throughout the study period, increasing size and more superficial positioning of the microcolonies within the beads were demonstrated by confocal laser scanning microscopy. More dead cells (measured by propidium iodide staining) were observed in the treated group of beads, which supports the results obtained by culture. Conclusions: The present study, simulating the clinical pharmacokinetics of tobramycin, demonstrates fast absorption of tobramycin in an in vitro biofilm model. In addition, this model system enables parallel investigation of pharmacokinetics and pharmacodynamics, providing a model for testing new treatment strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jac/dkv058

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 28

  1. Burmolle, 2010, Biofilms in chronic infections—a matter of opportunity—monospecies biofilms in multispecies infections, FEMS Immunol Med Microbiol, 59, 324, 10.1111/j.1574-695X.2010.00714.x · DOI · Paper page
  2. Stewart, 2002, Mechanisms of antibiotic resistance in bacterial biofilms, Int J Med Microbiol, 292, 107, 10.1078/1438-4221-00196 · DOI · Paper page
  3. Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science, 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
  4. Hall-Stoodley, 2009, Evolving concepts in biofilm infections, Cell Microbiol, 11, 1034, 10.1111/j.1462-5822.2009.01323.x · DOI · Paper page
  5. Jensen, 2010, The immune system vs. Pseudomonas aeruginosa biofilms, FEMS Immunol Med Microbiol, 59, 292, 10.1111/j.1574-695X.2010.00706.x · DOI · Paper page
  6. Costerton, 2011, New methods for the detection of orthopedic and other biofilm infections, FEMS Immunol Med Microbiol, 61, 133, 10.1111/j.1574-695X.2010.00766.x · DOI · Paper page
  7. Hall-Stoodley, 2012, Towards diagnostic guidelines for biofilm-associated infections, FEMS Immunol Med Microbiol, 65, 127, 10.1111/j.1574-695X.2012.00968.x · DOI · Paper page
  8. Romling, 2012, Biofilm infections, their resilience to therapy and innovative treatment strategies, J Intern Med, 272, 541, 10.1111/joim.12004 · DOI · Paper page
  9. Kiang, 2014, A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring, Clin Pharmacokinet, 53, 695, 10.1007/s40262-014-0152-3 · doi:10.1007/s40262-014-0152-3
  10. Udy, 2013, Clinical implications of antibiotic pharmacokinetic principles in the critically ill, Intensive Care Med, 39, 2070, 10.1007/s00134-013-3088-4 · DOI · Paper page
  11. Hoiby, 2011, The clinical impact of bacterial biofilms, Int J Oral Sci, 3, 55, 10.4248/IJOS11026 · DOI · Paper page
  12. Christophersen, 2012, Bead-size directed distribution of Pseudomonas aeruginosa results in distinct inflammatory response in a mouse model of chronic lung infection, Clin Exp Immunol, 170, 222, 10.1111/j.1365-2249.2012.04652.x · DOI
  13. Bjarnsholt, 2012, Understanding biofilms—are we there yet, FEMS Immunol Med Microbiol, 65, 125, 10.1111/j.1574-695X.2012.00984.x · doi:10.1111/j.1574-695x.2012.00984.x
  14. Macia, 2011, Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment, Antimicrob Agents Chemother, 55, 5230, 10.1128/AAC.00617-11 · DOI · Paper page
  15. Cerca, 2005, Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry, J Antimicrob Chemother, 56, 331, 10.1093/jac/dki217 · DOI · Paper page
  16. Hengzhuang, 2012, In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection, Antimicrob Agents Chemother, 56, 2683, 10.1128/AAC.06486-11 · DOI · Paper page
  17. Suci, 1994, Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms, Antimicrob Agents Chemother, 38, 2125, 10.1128/AAC.38.9.2125 · DOI · Paper page
  18. Stewart, 2009, Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm, Antimicrob Agents Chemother, 53, 3505, 10.1128/AAC.01728-08 · DOI · Paper page
  19. Bordi, 2011, Hacking into bacterial biofilms: a new therapeutic challenge, Ann Intensive Care, 1, 19, 10.1186/2110-5820-1-19 · DOI · Paper page
  20. Shigeta, 1997, Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method, Chemotherapy, 43, 340, 10.1159/000239587 · DOI · Paper page
  21. Nichols, 1988, Inhibition of tobramycin diffusion by binding to alginate, Antimicrob Agents Chemother, 32, 518, 10.1128/AAC.32.4.518 · DOI · Paper page
  22. Coquet, 1998, Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin, J Antimicrob Chemother, 42, 755, 10.1093/jac/42.6.755 · DOI · Paper page
  23. Walters, 2003, Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin, Antimicrob Agents Chemother, 47, 317, 10.1128/AAC.47.1.317-323.2003 · DOI · Paper page
  24. Xu, 1998, Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability, Appl Environ Microbiol, 64, 4035, 10.1128/AEM.64.10.4035-4039.1998 · DOI · Paper page
  25. Chiang, 2013, Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms, Antimicrob Agents Chemother, 57, 2352, 10.1128/AAC.00001-13 · DOI · Paper page
  26. Okshevsky, 2013, The role of extracellular DNA in the establishment, maintenance and perpetuation of bacterial biofilms, Crit Rev Microbiol, 4, 1
  27. Berney, 2007, Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight Kit in combination with flow cytometry, Appl Environ Microbiol, 73, 3283, 10.1128/AEM.02750-06 · DOI · Paper page
  28. Hengzhuang, 2011, Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms, Antimicrob Agents Chemother, 55, 4469, 10.1128/AAC.00126-11 · DOI · Paper page

Cited by

Metadata

Authors
Cao, B., Christophersen, L., Thomsen, K., Sønderholm, M., Bjarnsholt, T., Jensen, P. Ø., Høiby, N., & Moser, C.
Affiliations
  • 1  Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
  • 2  Institute of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
Venue
Journal of Antimicrobial Chemotherapy
Published
2015-03-18
Volume
70
Issue
7
Pages
2057-2063
ISSN
  • 1460-2091
  • 0305-7453
Cited by
68
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.